A. . S, V. M. . Rao, and S. P. R, “A Prospective Cross-sectional study to evaluate the utility of Fibroscan and Serum Biomarkers (APRI, FIB-4) for Non-Invasive Diagnosis of Liver Fibrosis in Metabolic dysfunction associated fatty liver disease (MAFLD) patients in a tertiary care center”, J Neonatal Surg, vol. 14, no. 21S, pp. 848–854, May 2025.